Tiziana Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	18.12	42.19	65.82	0.2	5.3	0.06	5.8
Cash & Cash Equivalents	18.12	42.19	65.82	0.2	5.3	0.06	5.8
Cash Growth	-57.04%	-35.91%	32812.00%	-96.23%	8187.50%	-98.90%	-
Receivables	1.91	1.76	1.31	0.78	0.59	2.38	0.39
Other Current Assets	4.25	4.74	3.05	0.53	1.02	0	0
Total Current Assets	24.28	48.68	70.18	1.51	6.91	2.45	6.2
Property, Plant & Equipment	0.39	0.02	0.36	0.44	0.01	0.02	0.04
Long-Term Investments	1.81	0	0	0	0	0	0
Goodwill and Intangibles	0	0.13	0.12	0	0	0	0
Other Long-Term Assets	0	0	0	0.43	0	0	0
Total Long-Term Assets	2.2	0.15	0.48	0.87	0.01	0.02	0.04
Total Assets	26.48	48.83	70.66	2.38	6.92	2.47	6.23
Accounts Payable	6.53	7.54	7.31	6.99	6.4	4.75	2.14
Current Debt	0.12	0	0.59	0.28	0	0	0
Other Current Liabilities	0.01	0.01	0.09	0.08	0	0	0
Total Current Liabilities	6.66	7.55	7.98	7.35	6.4	4.75	2.14
Long-Term Debt	0.24	0	0.29	0.54	0	0	0
Total Long-Term Liabilities	0.24	0	0.29	0.54	0	0	0
Total Liabilities	6.91	7.55	8.27	7.89	6.4	4.75	2.14
Total Debt	0.37	0	0.88	0.82	0	0	0
Debt Growth	-	-	7.20%	-	-	-	-
Retained Earnings	-116.26	-108.06	-84.65	-60.04	-50.72	-42.61	-29.73
Comprehensive Income	-3.13	0.45	5.41	1.94	1.97	2	2.77
Shareholders' Equity	19.57	41.28	62.39	-5.51	0.52	-2.28	4.09
Net Cash / Debt	17.76	42.19	64.95	-0.62	5.3	0.06	5.8
Net Cash / Debt Growth	-57.91%	-35.04%	-	-	8187.50%	-98.90%	-
Working Capital	17.62	41.13	62.2	-5.85	0.51	-2.3	4.05
Book Value Per Share	0.19	0.42	0.91	-0.08	0.01	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).